Stocky turns companies like Bayer AG N into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Avoid. Bayer scores below 30 on both Growth (28) and Value (31) Compounder metrics, signaling weak earnings expansion and uncompelling valuation for equity investors. Leadership Alignment is middling (51/100), and the Vulnerable profile indicates structural headwinds that a modest forward P/E of 10.4 cannot offset.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Bayer AG N:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 28/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates Bayer AG N (BAYN.DE) at 28/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. Bayer scores below 30 on both Growth (28) and Value (31) Compounder metrics, signaling weak earnings expansion and uncompelling valuation for equity investors. Leadership Alignment is middling (51/100), and the Vulnerable profile ind
BAYN.DE's current Stocky Verdict is 28/100, placing it in the "Avoid" band. This composite combines a 31/100 Compounder score, 51/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for Bayer AG N yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Bayer AG N scores 51/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Bayer AG N's Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Bayer AG N.
Sign up free and unlock the full analysis on BAYN.DE — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for BAYN.DE in the app.
